The FH Studies Collaboration
Familial Hypercholesterolaemia (FH) represents a major global health problem because, despite being very common, it is widely underdiagnosed, undertreated and, as a result often fatal. The consequences of FH in the form of premature atherosclerosis and cardiovascular events are potentially preventable, but require effective initiatives and policies to address the current issues and reduce the burden of disease.
To address these issues, EAS FH Studies Collaboration (FHSC) has since 2015 collected data from FH investigators from all over the world. The data is pooled, harmonised and analysed to give the investigators a better understanding of FH. EAS FHSC raises awareness of the disease and encourages the development of programmes, initiatives and policies specifically focused on FH, by joining efforts from healthcare providers, patient organizations, policy makers and the entire medical community. Read more
Latest news
- Debunking the myth: familial hypercholesterolaemia does not protect against diabetesThe FHSC Investigators, led by the FHSC Coordinating Centre at Imperial College London, present an article titled Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study that was published this month in Lancet Diabetes and Endocrinology. Familial hypercholesterolaemia (FH), a genetic … Read more
- Latest from the FHSC registry: take action now for universal cholesterol screening in early lifeCommentary to publication: Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study. The Lancet; https://doi.org/10.1016/S0140-6736(23)01842-1. Familial hypercholesterolaemia (FH) is the most common inherited lipid disorder, affecting about one in 300 people worldwide (1). If untreated, elevated low-density lipoprotein cholesterol (LDL‑C) levels from birth confer an increased risk of premature atherosclerotic cardiovascular disease. … Read more
- Global FHSC registry makes the case for universal cholesterol screening of children for familial hypercholesterolaemiaDecember 13, 2023 – Gothenburg, Sweden Finding children with familial hypercholesterolaemia (FH), the most common inherited lipid disorder, relies on family cascade screening, usually after a parent or relative has a heart attack, as physical signs of FH in children are uncommon, meaning that detection is delayed in most. These were the key findings from … Read more
- Consensus on Familial Hypercholesterolaemia in Children and AdolescentsFamilial Hypercholesterolaemia in children and adolescents: gaining decades of life by optimising detection and treatment Consensus Statement of the European Atherosclerosis Society Publication in full Featured Commentary Slide set Authors Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, Ose L, Averna M, Boileau C, Borén J, Bruckert E, Catapano AL, Defesche … Read more
- Consensus on FHFamilial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease Consensus Statement of the European Atherosclerosis Society Publication in full Slide set Featured Commentary Authors Børge G. Nordestgaard*, M. John Chapman*, Steve E. Humphries, Henry N. Ginsberg, Luis Masana, Olivier S. Descamps, Olov Wiklund, Robert A. Hegele, … Read more
